National Comprehensive Cancer Network
- NCCN
Guidelines®- End User License Agreement
- NCCN Guidelines for
Treatment of Cancer by Site- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Anal Carcinoma
- Basal and Squamous Cell Skin Cancers
- Bladder Cancer
- Bone Cancer
- Breast Cancer
- Central Nervous System Cancers
- Cervical Cancer
- Chronic Myelogenous Leukemia
- Colon Cancer
- Dermatofibrosarcoma Protuberans
- Esophageal and Esophagogastric Junction Cancers
- Gastric Cancer
- NCCN Guidelines for Detection,
Prevention, & Risk Reduction - NCCN Guidelines for
Supportive Care - NCCN Guidelines for
Age Related Recommendations - NCCN Guidelines for Patients®
- International Adaptations & Translations
- NCCN Pocket Guidelines
- NCCN Disclosure Policies &
Potential Conflicts of Interest - Licensing and Permissions
- Stay up-to-date with
NCCN Flash Updates™ - NCCN Guidelines Apps
- NCCN
Compendia- End User License Agreement
- NCCN Compendium®
- NCCN Biomarkers Compendium™
- Subscribe to the NCCN Compendia
- Licensing and Permissions
- Subscriptions
& Products- NCCN Compendium
- NCCN Biomarkers Compendium
- NCCN Templates
- Combination Subscriptions
- NCCN Flash Updates™
- NCCN Flash Updates™ Coupons
- NCCN Trends™ Surveys & Data
- NCCN Academy Video Modules
- NCCN eBulletin Newsletter
- NCCN Health Information Technology Licensees
- JNCCN — Journal of the National Comprehensive Cancer Network
- Advertising Opportunities
- NCCN Online Catalog
- Clinical & Business
Resources- Members Only
- NCCN Corporate Council
- NCCN Academy
- NCCN Insights: Analytics, Research & Consulting
- NCCN Resource Tool: REMS
- NCCN Collaboration with the National Business Group on Health
- NCCN Virtual Reimbursement Resource Room
- NCCN Health Information Technology Licensees
- NCCN Oncology Policy Program White Papers
- NCCN Oncology Research Program (ORP)
- ORP Recent News
- NCCN ORP Affiliate Research Project
- ORP Scientific Publications
- ORP Investigator Steering Committee
- ORP Testimonials
- Clinical Trials at NCCN Member Institutions
- Find ORP Funded Clinical Trials at NCCN Member Institutions
- NCCN Specialized Imaging Research Consortium™ (SIRC)
- NCCN ORP Disclosure Policy
- NCCN ORP for Industry
- NCCN Informed Consent Language Database
- NCCN Content Policies
- Patient
Resources- NCCN Guidelines for Patients®
- NCCN Website for Patients and
Caregivers - NCCN.com - Find an NCCN Member Institution
- Find an NCCN Cancer Center Near You
- Information on Patient Assistance & Reimbursement Help
- NCCN Virtual Reimbursement Resource Room Guide
- Find Clinical Trials
- NCCN Foundation
- Donate to the NCCN Foundation
About NCCN
Non-Melanoma Skin Cancer Panel - Disclosures as of 2/27/2012
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Murad Alam, MD, MSCI |
None |
None |
None |
None |
11/7/2012 |
James S. Andersen, MD |
Allergan |
None |
None |
None |
11/23/2012 |
Daniel Berg, MD |
None |
Genentech, Inc. |
None |
None |
11/5/2012 |
Christopher K. Bichakjian, MD |
None |
None |
None |
None |
10/17/2012 |
Glen M. Bowen, MD |
None |
None |
None |
None |
5/31/2013 |
Richard T. Cheney, MD |
None |
None |
None |
None |
7/3/2012 |
Lauren Gallagher, RPh, PhD |
None |
None |
None |
None |
6/18/2013 |
L. Frank Glass, MD |
None |
None |
None |
None |
2/9/2012 |
Kristina M. Gregory, RN, MSN, OCN |
None |
None |
None |
None |
10/23/2012 |
Roy C. Grekin, MD |
Genentech, Inc. |
None |
None |
None |
12/7/2011 |
Kenneth Grossmann, MD, PhD |
None |
Bristol-Myers Squibb Company |
None |
None |
3/11/2013 |
Alan L. Ho, MD, PhD |
None |
AstraZeneca Pharmaceuticals LP; |
None |
None |
11/8/2012 |
Maria Ho, PhD |
None |
None |
None |
None |
8/3/2012 |
Nanette Liegeois, MD, PhD |
None |
Genentech, Inc. |
None |
None |
2/27/2012 |
Daniel D. Lydiatt, DDS, MD |
None |
None |
None |
None |
12/7/2011 |
Joan S. McClure, MS |
None |
None |
None |
None |
7/23/2012 |
Nicole McMillian, MS |
None |
None |
None |
None |
3/27/2013 |
Jeff Michalski, MD, MBA |
None |
None |
None |
None |
8/13/2012 |
Stanley J. Miller, MD |
None |
None |
None |
None |
2/23/2012 |
William H. Morrison, MD |
None |
None |
Merck & Co., Inc.; |
None |
8/24/2012 |
Kishwer S. Nehal, MD |
None |
None |
None |
None |
6/3/2013 |
Kelly C. Nelson, MD |
None |
None |
None |
None |
11/5/2012 |
Paul Nghiem, MD, PhD |
None |
None |
None |
None |
10/9/2012 |
Thomas Olencki, DO |
None |
Genentech, Inc.; |
None |
None |
3/4/2013 |
Clifford S. Perlis, MD, MBe |
Novartis Pharmaceuticals Corporation |
Genentech, Inc. |
None |
None |
2/4/2012 |
Ashok R. Shaha, MD |
None |
None |
None |
None |
3/7/2013 |
Malika Tuli, MD |
None |
None |
None |
None |
10/10/2012 |
Marshall M. Urist, MD |
None |
None |
None |
None |
5/2/2013 |
Andrew E. Werchniak, MD |
None |
None |
None |
None |
11/9/2012 |
John A. Zic, MD |
None |
None |
None |
None |
8/17/2012 |
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved